PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease
- 12 December 2016
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (5) , 962-977
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosisJournal of Clinical Investigation, 2012
- On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1Genes & Development, 2012
- PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 ActivationCell Metabolism, 2011
- Signaling Mechanism of Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Inflammatory DiseasesThe American Journal of Pathology, 2011
- Peroxisome Proliferator-Activated Receptor Alpha Target GenesPPAR Research, 2010
- Comparative Analysis of Gene Regulation by the Transcription Factor PPARα between Mouse and HumanPLOS ONE, 2009
- Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 RatsThe American Journal of Pathology, 2009
- Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and InflammationCell Metabolism, 2009
- Peroxisome Proliferator Activated Receptors and Lipoprotein MetabolismPPAR Research, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005